Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 111.16B P/E 17.58 EPS this Y 12.50% Ern Qtrly Grth 12.90%
Income 6.24B Forward P/E 12.74 EPS next Y 11.60% 50D Avg Chg 4.00%
Sales 171.75B PEG 1.18 EPS past 5Y 15.52% 200D Avg Chg -2.00%
Dividend 1.00% Price/Book 2.91 EPS next 5Y 12.10% 52W High Chg -14.00%
Recommedations 1.80 Quick Ratio 1.22 Shares Outstanding 232.42M 52W Low Chg 14.00%
Insider Own 0.21% ROA 5.78% Shares Float 231.79M Beta 0.81
Inst Own 92.22% ROE 15.96% Shares Shorted/Prior 1.94M/2.34M Price 471.72
Gross Margin 27.75% Profit Margin 3.64% Avg. Volume 1,369,872 Target Price 604.69
Oper. Margin 7.53% Earnings Date Jul 17 Volume 932,969 Change 0.80%
About Elevance Health, Inc.

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits. The company operates in the pharmacy services business; and markets and offers pharmacy services, including pharmacy benefit management, as well as home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services. In addition, it provides healthcare-related services and capabilities, including utilization management, behavioral health, integrated care delivery, palliative care, payment integrity services, subrogation services, and health and wellness programs, as well as services related to data management, information technology, and business operations. Further, the company is involved in the National Government Services business. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brand names. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.

Elevance Health, Inc. News
04/24/24 Why Elevance Health (ELV) is a Top Growth Stock for the Long-Term
04/24/24 The Zacks Analyst Blog Highlights Meta Platforms, Elevance Health, Canadian Natural Resources, The Coca-Cola and The Progressive
04/23/24 Top Research Reports for Meta Platforms, Elevance Health & Canadian Natural Resources
04/23/24 Why Elevance Health (ELV) is a Top Value Stock for the Long-Term
04/22/24 Insurer Earnings Make Hospital Investors Sweat
04/22/24 Elevance Health (NYSE:ELV) Will Pay A Dividend Of $1.63
04/19/24 Elevance Health Inc. (NYSE:ELV) Q1 2024 Earnings Call Transcript
04/19/24 Elevance Health First Quarter 2024 Earnings: EPS Misses Expectations
04/19/24 Elevance Health Inc (ELV) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and ...
04/19/24 Decoding Elevance Health Inc (ELV): A Strategic SWOT Insight
04/18/24 Q1 2024 Elevance Health Inc Earnings Call
04/18/24 13 Best Low Volatility Stocks to Buy According to Hedge Funds
04/18/24 Elevance Health (ELV) Q1 2024 Earnings Call Transcript
04/18/24 Elevance Health Clocks $2.2B Q1 Net Profit Despite 21% Drop In Medicaid Enrollment, Lifts Annual Guidance
04/18/24 Elevance (ELV) Q1 Earnings Beat on Rate Hikes, Guidance Raised
04/18/24 Elevance Health Offers More Relief on Medical Costs for Worried Investors
04/18/24 Elevance Raises Forecast Amid Industry Cyberattack Concerns
04/18/24 Compared to Estimates, Elevance Health (ELV) Q1 Earnings: A Look at Key Metrics
04/18/24 14 Best Large Cap Dividend Growth Stocks To Buy Now
04/18/24 Elevance Health (ELV) Beats Q1 Earnings Estimates
ELV Chatroom

User Image kagrawala Posted - 22 hours ago

$HUM i am so thankful i did not fall for the HUM bandwagon- their management is truly awful. Long $unh & $elv

User Image Nosh Posted - 1 day ago

$UNH $HUM Locked in some profits on these two...will look lower or go into $ELV on a pullback.

User Image crtlabz Posted - 1 day ago

$ELV

User Image hodllow Posted - 5 days ago

$ELV

User Image hodllow Posted - 5 days ago

$ELV 2 large inverted hammer candles on the daily. Extremely bearish, this could see a significant price drop

User Image THE_TRADE Posted - 5 days ago

$CVS $UNH $HUM $ELV CVS earnings report should be juicy like their dividend ๐Ÿ‚

User Image Simon77 Posted - 5 days ago

$CVS cheapest defensive piece to play. Pile in. Have rallied with the rest $UNH $HUM $ELV

User Image DonCorleone77 Posted - 6 days ago

$ELV Elevance Health price target raised to $621 from $584 at Barclays Barclays analyst Andrew Mok raised the firm's price target on Elevance Health to $621 from $584 and keeps an Overweight rating on the shares post the Q1 report. The analyst remains positive on Elevance following its "positively differentiated" cost trend, solid execution in Carelon, and "guarded optimism" in Medicare.

User Image mikesterz7 Posted - 6 days ago

$ELV Elevance Health Inc. reported Q1 EPS of $10.64, $0.16 better than the analyst estimate of $10.48. Revenue for the quarter came in at $42.3 billion versus the consensus estimate of $42.47 billion. GUIDANCE: Elevance Health Inc. sees FY2024 EPS at greater of $37.20, versus the consensus of $37.15.

User Image crtlabz Posted - 6 days ago

$ELV

User Image Elev8edTrader Posted - 6 days ago

$ELV Elevance Health Shares Rise After Q1 Results Top Estimates, Analysts Boost Price Targets

User Image ryohwang Posted - 6 days ago

$ELV back to 520, the ER is ok nothing good nothing bad but the sp already at recent high

User Image kagrawala Posted - 6 days ago

$UNH $ELV moral of the story - make outsized bets based on fact - not just herd mentality. Everyone was not seeing the forest though the trees.

User Image cubie Posted - 6 days ago

@lukenight @simon58 @jargv @jenbunn @randydeansr @keywestave01 @TraderRapp @ykante @kindness123 @CVT318 and sector rule๐Ÿ˜๐Ÿ˜… $elv also peaked (temporarily at least) 14 minutes ago and pullback $5, $unh just did same, can't make this sht up Simon

User Image cubie Posted - 6 days ago

@jenbunn @simon58 @jargv @randydeansr @keywestave01 @ykante @TraderRapp @kindness123 @lukenight @CVT318 fudge should've strangled $unh for $elv earnings ๐Ÿ˜ข๐Ÿ˜ญ

User Image MyStocksZoom Posted - 6 days ago

$CANOQ Member engagement team being trained by $ELV. Looks like a takeover in the works. Don't mind if $UNH crash the party and start a bidding war.

User Image cubie Posted - 6 days ago

$UNH wowee, thanks a lot $elv ๐Ÿ˜…

User Image trigger_finger Posted - 6 days ago

$ELV Lets get over 540

User Image cubie Posted - 6 days ago

@simon58 @jargv @jenbunn @randydeansr @keywestave01 @kindness123 @TraderRapp @ykante @lukenight @CVT318 $unh $elv $hum $ci cubie treasure trove of info!!

User Image AivelX Posted - 6 days ago

Good morning everyone ๐ŸŒ† $ELV and $TSM very nice earnings reaction according to the most probable scenarios we posted yesterday ๐Ÿ‘‡ Stay tuned, today before the close we'll share our latest insights for $NFLX โšก๏ธ Early Access >> https://aivelx.com << #AivelX #AI #Earnings

User Image healthcareguru Posted - 6 days ago

$ELV pop and now bleed outโ€ฆ no reason to own this now.

User Image RockyTSTH Posted - 6 days ago

$ELV Elevance Health Q1 2024 Adj EPS $10.64 Beats $10.53 Estimate, Sales $42.273B Miss $42.626B Estimate Elevance Health Forecasts 2024 Revises FY2024 Adjusted EPS Guidance To Over $37.20 Versus Prior Outlook Of Over $37.10 And Consensus Of $37.15

User Image briefingcom Posted - 6 days ago

$ELV: Elevance Health raised its FY24 EPS above consensus https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20240418062813ELV&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page

User Image OpenOutcrier Posted - 6 days ago

$ELV (+2.8% pre) Elevance Health (ELV) Beats Q1 Earnings Estimates - Zacks https://ooc.bz/l/30741

User Image cubie Posted - 6 days ago

@simon58 @jargv @mj_ryder @jenbunn @randydeansr @keywestave01 @kindness123 @TraderRapp @tonyctl @lukenight mj u here?๐Ÿ˜… $dhi on watch to short , preferably near round number also jargv, u gonna short $unh again?๐Ÿ˜…, $elv small pop. playing $hum for $elv like for $unh wouldn't had worked so far today๐Ÿ˜…

User Image kagrawala Posted - 1 week ago

$ELV & $UNH my two plays into insurance. Both looking good. 70% of the investment is UNH the rest ELV. Good luck all ๐Ÿ€

User Image Tokenist Posted - 1 week ago

๐ŸšจEARNINGS ALERT๐Ÿšจ Notable earnings released for today: Elevance Health $ELV: $10.64 EPS vs $10.48 est. / $42.3B Revenue vs $42.47B est DR Horton $DHI: $3.52 EPS vs $3.07 est. / $9.1B Revenue vs $8.15B est Genuine Parts $GPC: $2.22 EPS vs $2.17 est. / $5.8B Revenue vs $5.84B est Blackstone $BX: $0.98 EPS vs $0.9682 est. / $3.69B Revenue vs $2.56B est

User Image Estimize Posted - 1 week ago

$ELV beats the Estimize EPS Consensus by 7c and misses the Estimize Revenue Consensus by $354.48M. Reports FQ1 earnings of $10.64 EPS a... http://www.estimize.com/elv/fq1-2024?utm_content=beat_or_miss&utm_medium=tweet&utm_source=stocktwits

User Image epsguid Posted - 1 week ago

$ELV reported earnings of $10.64, consensus was $10.54, Earnings Whisper was $10.70 via @eWhispers #whispermiss http://eps.sh/d/elv

User Image wallstengine Posted - 1 week ago

$ELV | Elevance Health Q1 Earnings Highlights: ๐Ÿ”น EPS: $10.64 (Est. $10.48) ๐ŸŸข ๐Ÿ”น Revenue: $42.3B (Est. $42.47B) ๐Ÿ”ด ๐Ÿ”น Medical Enrollment Members: 46.2M FY'4 Guidance: ๐Ÿ”น Adj. EPS: Over $37.20 (Prev. over $37.10, Est. $37.15) ๐ŸŸข Q1 Financial and Operational Metrics: ๐Ÿ”น Benefit Expense Ratio: 85.6%, an improvement of 20 basis points ๐Ÿ”น Days in Claims Payable: 49.0 days, up from 47.3 days at the end of 2023 Additional Insights: ๐Ÿ”น Dividend: Declared Q2 dividend of $1.63 ๐Ÿ”น Growth driven by higher premium yields, reflecting medical cost trend adjustments. ๐Ÿ”น Growth in Carelon, including full quarter revenue from BioPlus acquisition. ๐Ÿ”น Partial offset by attrition in Medicaid membership.

Analyst Ratings
Mizuho Buy Apr 24, 24
RBC Capital Outperform Apr 19, 24
UBS Buy Apr 19, 24
Wells Fargo Overweight Apr 19, 24
Truist Securities Buy Apr 19, 24
Jefferies Buy Apr 19, 24
Barclays Overweight Apr 19, 24
Cantor Fitzgerald Overweight Apr 10, 24
Wells Fargo Overweight Apr 8, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Dixon Robert L JR Director Director Jul 21 Sell 476.71 310 147,780 9,638 07/21/23
Kendrick Charles Morgan JR EVP & President, Com.. EVP & President, Commercial Jun 09 Option 280.62 6,328 1,775,763 20,857 06/13/22
Kendrick Charles Morgan JR EVP & President, Com.. EVP & President, Commercial Jun 09 Sell 489.56 6,328 3,097,936 14,529 06/13/22
PERU RAMIRO G Director Director May 18 Sell 468.88 990 464,191 9,405 05/20/22
Haytaian Peter D EVP & Pres., DBG & I.. EVP & Pres., DBG & IngenioRx Mar 10 Option 131.8 1,848 243,566 29,864 03/14/22
Haytaian Peter D EVP & Pres., DBG & I.. EVP & Pres., DBG & IngenioRx Mar 10 Sell 461.16 17,703 8,163,915 12,161 03/14/22
Penczek Ronald W CAO & Controller CAO & Controller Mar 01 Option 296.81 1,559 462,727 4,325 03/03/22
Penczek Ronald W CAO & Controller CAO & Controller Mar 01 Sell 463.68 2,423 1,123,497 1,902 03/03/22
Haytaian Peter D EVP & President, Com.. EVP & President, Commercial Dec 17 Option 146.93 5,833 857,043 38,475 12/17/20
Haytaian Peter D EVP & President, Com.. EVP & President, Commercial Dec 17 Sell 312.73 5,833 1,824,154 32,642 12/17/20
Haytaian Peter D EVP & President, Com.. EVP & President, Commercial Nov 18 Option 123.85 1,708 211,536 38,476 11/18/20
Haytaian Peter D EVP & President, Com.. EVP & President, Commercial Nov 18 Sell 333.9 5,834 1,947,973 32,642 11/18/20
ZIELINSKI THOMAS C EVP & General Counse.. EVP & General Counsel Nov 04 Option 232.04 1,893 439,252 19,803 11/04/20
ZIELINSKI THOMAS C EVP & General Counse.. EVP & General Counsel Nov 04 Sell 292.35 9,175 2,682,311 17,910 11/04/20